46,XY difference of sex development due to impaired androgen production Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for 46,XY difference of sex development due to impaired androgen production.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Voraxaze

BTG International Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Voraxaze

(glucarpidase)Orphan drugstandard

BTG International Inc.

Carboxypeptidase [EPC]

12.1 Mechanism of Action Glucarpidase is a recombinant bacterial enzyme that hydrolyzes the carboxyl- terminal glutamate residue from folic acid and c...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for 46,XY difference of sex development due to impaired androgen production.
Search all trials →

Search clinical trials for 46,XY difference of sex development due to impaired androgen production →

Recent News & Research

No recent news articles indexed yet for 46,XY difference of sex development due to impaired androgen production.
Search PubMed for 46,XY difference of sex development due to impaired androgen production →

Browse all 46,XY difference of sex development due to impaired androgen production news →

Specialist Network

No specialists currently listed for 46,XY difference of sex development due to impaired androgen production.

View all 46,XY difference of sex development due to impaired androgen production specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰